Bayer: Takeover offer for Schering successful
Bayer now controls 88.0 percent of issued and outstanding Schering shares
The way is now clear for the Bayer Group to acquire Berlin-based pharmaceuticals company Schering AG. Bayer has gained control of a total of 88.0 percent of Schering's approximately 191 million issued and outstanding shares. The attainment of a three-quarters majority was the last remaining condition of the takeover offer. Both the E.U. Commission and the U.S. antitrust authorities had already given their unconditional approval.
By the expiration of the acceptance period on June 14, 2006, 87.3 million Schering shares had been tendered to Bayer under the takeover offer. This is equivalent to 45.7 percent of the issued and outstanding Schering shares. In addition, by the same date, Bayer had acquired 77.8 million Schering shares, or 40.7 percent of the issued and outstanding Schering shares, either on the stock market or directly. The minimum acceptance threshold of 75 percent was therefore exceeded. A further 2.9 million Schering shares, or 1.5 percent, were purchased by the Bayer Group thereafter.
"We're pleased to have received such broad-based support from the stockholders," said Bayer Management Board Chairman Werner Wenning. "We also invite the remaining Schering stockholders to accept our attractive offer of EUR 89 per share," he added, pointing out that the additional acceptance period runs from June 23 until July 6, 2006. Bayer continues to pursue its goal of wholly acquiring Schering.
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
